Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

PPD Buys BioDuro, Its Second Major China CRO Acquisition This Month

publication date: Nov 18, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

PPD, Inc. is quickly building up its China-based CRO capability. The company announced it will acquire BioDuro LLC, a CRO based in Beijing whose 660 employees focus on drug discovery. The acquisition complements PPD’s purchase of Excel PharmaStudies earlier this month. Excel is a CRO that conducts Phase II through Phase IV clinical trials from its offices throughout China. PPD did not disclose financial details of either transaction. More details...

Stock Symbol: (NSDQ: PPDI)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...